93 related articles for article (PubMed ID: 7544155)
1. Expression of the proto-oncogene rhombotin-2 is identical to the acute phase response protein metallothionein, suggesting multiple functions.
Neale GA; Mao S; Parham DM; Murti KG; Goorha RM
Cell Growth Differ; 1995 May; 6(5):587-96. PubMed ID: 7544155
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of rhombotin-2 causes selective expansion of CD4-CD8- lymphocytes in the thymus and T-cell tumors in transgenic mice.
Neale GA; Rehg JE; Goorha RM
Blood; 1995 Oct; 86(8):3060-71. PubMed ID: 7579400
[TBL] [Abstract][Full Text] [Related]
3. Disruption of T-cell differentiation precedes T-cell tumor formation in LMO-2 (rhombotin-2) transgenic mice.
Neale GA; Rehg JE; Goorha RM
Leukemia; 1997 Apr; 11 Suppl 3():289-90. PubMed ID: 9209368
[TBL] [Abstract][Full Text] [Related]
4. Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression.
Boehm T; Spillantini MG; Sofroniew MV; Surani MA; Rabbitts TH
Oncogene; 1991 May; 6(5):695-703. PubMed ID: 2052354
[TBL] [Abstract][Full Text] [Related]
5. Elf-2, a rhombotin-2 binding ets transcription factor: discovery and potential role in T cell leukemia.
Wilkinson DA; Neale GA; Mao S; Naeve CW; Goorha RM
Leukemia; 1997 Jan; 11(1):86-96. PubMed ID: 9001422
[TBL] [Abstract][Full Text] [Related]
6. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
Gratiot-Deans J; Ding L; Turka LA; Nuñez G
J Immunol; 1993 Jul; 151(1):83-91. PubMed ID: 8326141
[TBL] [Abstract][Full Text] [Related]
7. [The cloning and analysis of a single gene in Drosophila homologic with human oncogene TTG].
Zhu T; Paro R; Royer-pokora B
Yi Chuan Xue Bao; 1996; 23(6):409-18. PubMed ID: 9084220
[TBL] [Abstract][Full Text] [Related]
8. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis.
Rabbitts TH; Axelson H; Forster A; Grutz G; Lavenir I; Larson R; Osada H; Valge-Archer V; Wadman I; Warren A
Leukemia; 1997 Apr; 11 Suppl 3():271-2. PubMed ID: 9209362
[TBL] [Abstract][Full Text] [Related]
10. High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells.
Karsunky H; Mende I; Schmidt T; Möröy T
Oncogene; 2002 Feb; 21(10):1571-9. PubMed ID: 11896586
[TBL] [Abstract][Full Text] [Related]
11. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2.
Larson RC; Fisch P; Larson TA; Lavenir I; Langford T; King G; Rabbitts TH
Oncogene; 1994 Dec; 9(12):3675-81. PubMed ID: 7970726
[TBL] [Abstract][Full Text] [Related]
12. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of the developmentally regulated NFI gene family during phorbol ester-induced differentiation of human leukemic cells.
Kulkarni S; Gronostajski RM
Cell Growth Differ; 1996 Apr; 7(4):501-10. PubMed ID: 9052991
[TBL] [Abstract][Full Text] [Related]
15. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester.
Bott CM; Doshi JB; Li LL; McMurtry SA; Sanders JL; Fox DA
J Immunol; 1994 Jul; 153(1):1-9. PubMed ID: 8207228
[TBL] [Abstract][Full Text] [Related]
17. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
Grutz G; Forster A; Rabbitts TH
Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
[TBL] [Abstract][Full Text] [Related]
18. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
[TBL] [Abstract][Full Text] [Related]
19. T-cell proto-oncogene rhombotin-2 is a complex transcription regulator containing multiple activation and repression domains.
Mao S; Neale GA; Goorha RM
J Biol Chem; 1997 Feb; 272(9):5594-9. PubMed ID: 9038167
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-theta (PKCtheta) distribution analysis in hematopoietic cells: proliferating T cells exhibit high proportions of PKCtheta in the particulate fraction.
Meller N; Elitzur Y; Isakov N
Cell Immunol; 1999 May; 193(2):185-93. PubMed ID: 10222061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
